Research studies have explored the use of psychedelic substances, in combination with psychotherapy, in end-of-life care. Some studies suggest that, when used legally and in a therapeutic setting, psychedelics may contribute to reductions in symptoms such as anxiety, depression, and existential distress in individuals with terminal illnesses.
